Officials with the FDA have approved crisaborole (Eucrisa) ointment, 2%, for use in children as young as 3 months of age with mild-to-moderate atopic dermatitis.
DW Weekly: FDA approves crisaborole for AD patients as young as three months
Officials with the FDA have approved crisaborole (Eucrisa) ointment, 2%, for use in children as young as 3 months of age with mild-to-moderate atopic dermatitis.